MedPath

Propolis for Management of Chemotherapy-Induced Oral Mucositis in Pediatric Patients

Not Applicable
Not yet recruiting
Conditions
Oral Mucositis Due to Chemotherapy
Interventions
Drug: chlorohexidine mouthwash and topical antifungal
Registration Number
NCT07073092
Lead Sponsor
Ain Shams University
Brief Summary

The goal of this clinical trial is to evaluate the efficacy of propolis in the prevention of oral mucositis and reducing pain score in children undergoing chemotherapy, and assessing its impact on body mass index, pediatric quality of life and total antioxidant assay. The main question it aims to answer is:

What is the effect of propolis on oral mucositis scores in children undergoing chemotherapy?

Participants will:

Take propolis 3 times daily for 21 days follow up weekly for 3 weeks

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Children of both genders less than 18 years receiving intensive chemotherapy.

  • Oncology patients receiving intensified chemotherapy at Oncology unit, Children's Hospital, Ain Shams University, Egypt, who meet the following criteria:

    • Taking intensified chemotherapy
    • A healthy oral mucosa.
Exclusion Criteria
  • Allergy to bee products.
  • Severe systemic illness unrelated to cancer (Diabetes, Hypertension, ...)
  • Inability to take oral medication or unwillingness to participate in the study
  • Radiotherapy in the head and neck area.
  • Malignant or potentially malignant lesions of the oral cavity.
  • Undergoing any other procedures to prevent oral mucositis except standard oral care.
  • Patients are unable to commit to the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
study grouppropolispropolis medicated jelly candy+ standard oral care (chlorohexidine and topical anti-fungal) three times daily for 21 days
study groupchlorohexidine mouthwash and topical antifungalpropolis medicated jelly candy+ standard oral care (chlorohexidine and topical anti-fungal) three times daily for 21 days
control groupchlorohexidine mouthwash and topical antifungalStandard oral care (chlorohexidine mouth wash and topical anti-fungal) three times daily for 21 days
Primary Outcome Measures
NameTimeMethod
oral mucositis score (WHO)3 weeks

Assess the effectiveness of propolis in treatment of chemotherapy induced oral mucositis in pediatric cancer patients using the WHO Scale (WHO), scoring from 0 to 4.

Secondary Outcome Measures
NameTimeMethod
pain (VAS)3 weeks

Assess the effectiveness of propolis on pain levels. Pain will be assessed by (visual analogue scale). The P-VAS evaluation ranges from 0 to 10, where 0 indicates "no pain" and 10 indicates "the most severe pain"

body mass index3 weeks

Assess the effectiveness of propolis on BMI in pediatric patients undergoing chemotherapy. Body mass index (BMI, kg/m2) was defined as the body mass (kg) divided by the square of the body height (m).

Pediatric Quality of Life3 weeks

Assess the effectiveness of propolis on Pediatric Quality of Life using the Arabic validated version of Peds QL™ Inventory both Child Self Report and Parent Proxy Report.

0 = Never, 1 = Almost Never, 2 = Sometimes, 3 = Often, 4 = Almost Always

Scoring Method:

1. Reverse Scoring System: 0 = 100 points, 1 = 75 points, 2 = 50 points, 3 = 25 points, 4 = 0 points 2. Domain Score Calculation: Sum all question scores within a domain and divide by the number of questions in that domain.

3. Total PedsQL Score Calculation: Sum all domain scores and divide by the total number of questions. Higher scores indicate better quality of life.

Total anti-oxidant assay3 weeks

Assess the effectiveness of propolis on total antioxidant assay in pediatric patients undergoing chemotherapy using biochemical analysis

Trial Locations

Locations (1)

faculty of dentistry Ain shams university

🇪🇬

Cairo, Egypt

faculty of dentistry Ain shams university
🇪🇬Cairo, Egypt
Dina B. Elkhouly
Contact
+201063147477
dinaborham@dent.asu.edu.eg

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.